Paper36944946
Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
Shi P and 6 others. J Nanobiotechnology, 2023. Cited by 109 papers, by iCite.
Cite this record
ConductScience Library. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics. Papers, record 36944946. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944946
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Osteosarcoma | Major topic |
| Bone Neoplasms | Major topic |
| Nanoparticles | Major topic |
| Humans | |
| Nanoparticle Drug Delivery System | |
| Ligands | |
| Drug Carriers |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81974348 | National Natural Science Foundation of China | PubMed |
Source PubMed
References247
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32235073 | CD271 antibody-functionalized HGNs for targeted photothermal therapy of osteosarcoma stem cells. | Nanotechnology | 2020 | https://conductscience.org/library/papers/32235073 | PubMed |
| 2 | 14766123 | Epidermal growth factor receptor: a promising target in solid tumours. | Cancer Treat Rev | 2004 | https://conductscience.org/library/papers/14766123 | PubMed |
| 3 | 35062957 | Peptide-based semiconducting polymer nanoparticles for osteosarcoma-targeted NIR-II fluorescence/NIR-I photoacoustic dual-model imaging and photothermal/photodynamic therapies. | J Nanobiotechnology | 2022 | https://conductscience.org/library/papers/35062957 | PubMed |
| 4 | 8701285 | Fighting cancer by attacking its blood supply. | Sci Am | 1996 | https://conductscience.org/library/papers/8701285 | PubMed |
| 5 | 35068931 | Cyclic RGD-Decorated Liposomal Gossypol AT-101 Targeting for Enhanced Antitumor Effect. | Int J Nanomedicine | 2022 | https://conductscience.org/library/papers/35068931 | PubMed |
| 6 | 24448245 | Universal marker and detection tool for human sarcoma circulating tumor cells. | Cancer Res | 2014 | https://conductscience.org/library/papers/24448245 | PubMed |
| 7 | 31781245 | The DNMT1/miR-34a Axis Is Involved in the Stemness of Human Osteosarcoma Cells and Derived Stem-Like Cells. | Stem Cells Int | 2019 | https://conductscience.org/library/papers/31781245 | PubMed |
| 8 | 30350653 | Real-Time Imaging of Free Radicals for Mitochondria-Targeting Hypoxic Tumor Therapy. | Nano Lett | 2018 | https://conductscience.org/library/papers/30350653 | PubMed |
| 9 | 24125772 | Nanoparticles of 2-deoxy-D-glucose functionalized poly(ethylene glycol)-co-poly(trimethylene carbonate) for dual-targeted drug delivery in glioma treatment. | Biomaterials | 2014 | https://conductscience.org/library/papers/24125772 | PubMed |
| 10 | 32451642 | Salinomycin-loaded PLA nanoparticles: drug quantification by GPC and wave voltammetry and biological studies on osteosarcoma cancer stem cells. | Anal Bioanal Chem | 2020 | https://conductscience.org/library/papers/32451642 | PubMed |
| 11 | 23334168 | Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. | Nat Nanotechnol | 2013 | https://conductscience.org/library/papers/23334168 | PubMed |
| 12 | 15001266 | A novel antiangiogenesis therapy using an integrin antagonist or anti-Flk-1 antibody coated 90Y-labeled nanoparticles. | Int J Radiat Oncol Biol Phys | 2004 | https://conductscience.org/library/papers/15001266 | PubMed |
| 13 | 28482484 | Folic acid-tagged titanium dioxide nanoparticles for enhanced anticancer effect in osteosarcoma cells. | Mater Sci Eng C Mater Biol Appl | 2017 | https://conductscience.org/library/papers/28482484 | PubMed |
| 14 | 6181069 | Vascularization of tumors: a review. | J Cancer Res Clin Oncol | 1982 | https://conductscience.org/library/papers/6181069 | PubMed |
| 15 | 34220512 | Light-Responsive Micelles Loaded With Doxorubicin for Osteosarcoma Suppression. | Front Pharmacol | 2021 | https://conductscience.org/library/papers/34220512 | PubMed |
| 16 | 33305647 | Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma. | Drug Deliv | 2020 | https://conductscience.org/library/papers/33305647 | PubMed |
| 17 | 32973147 | Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/32973147 | PubMed |
| 18 | 33659241 | Zoledronic Acid-Loaded Hybrid Hyaluronic Acid/Polyethylene Glycol/Nano-Hydroxyapatite Nanoparticle: Novel Fabrication and Safety Verification. | Front Bioeng Biotechnol | 2021 | https://conductscience.org/library/papers/33659241 | PubMed |
| 19 | 28656259 | Anti-angiogenesis target therapy for advanced osteosarcoma (Review). | Oncol Rep | 2017 | https://conductscience.org/library/papers/28656259 | PubMed |
| 20 | 17126026 | Genomic mechanisms and measurement of structural and numerical instability in cancer cells. | Semin Cancer Biol | 2007 | https://conductscience.org/library/papers/17126026 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 109 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42972414 | Translational design of multifunctional novasomes for theranostic-driven precision therapy of cutaneous oncology. | J Biol Eng | 2026 | https://conductscience.org/library/papers/42972414 | PubMed |
| 42942840 | Gold Nanoparticle-Enabled Cancer Therapy: Translational Design Rules for Photothermal-Immunotherapy and Multimodal Precision Oncology. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942840 | PubMed |
| 42942805 | Nanoparticle-Based Drug Delivery Systems for Anticancer Therapy: Microenvironment-Driven Strategies, Advances, and Challenges. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42942805 | PubMed |
| 42883170 | Reimagining Cannabidiol Delivery Through Carbon Nanodots. | Molecules | 2026 | https://conductscience.org/library/papers/42883170 | PubMed |
| 42760790 | Metabolic Reprogramming of Cancer Stem Cells: Targeting Lipid Flux and Mitochondrial Plasticity to Overcome Therapeutic Resistance. | Cancer Med | 2026 | https://conductscience.org/library/papers/42760790 | PubMed |
| 42751213 | Bio-Polymers Based Functionalized Hydrogel Carriers for Targeted Oncology Therapies: Current Progress and Future Perspectives. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42751213 | PubMed |
| 42690516 | Nanotherapeutics in osteosarcoma: Advances in miRNA nanocarriers and targeted drug delivery. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42690516 | PubMed |
| 42646415 | Anticancer Activity of Green Synthesized ZnO Nanoparticles from Ficus benghalensis Bark in Osteosarcoma Cells. | Nanomaterials (Basel) | 2026 | https://conductscience.org/library/papers/42646415 | PubMed |
| 42643094 | Breaking Physiological Barriers in Women's Health: Mucoadhesive and Stimuli-Responsive Nanomaterials. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | https://conductscience.org/library/papers/42643094 | PubMed |
| 42559258 | Ligand-modified multifunctional liposome-based targeted delivery platform: a multimodal cancer combination therapy strategy. | Theranostics | 2026 | https://conductscience.org/library/papers/42559258 | PubMed |
| 42294255 | Strategies for Enhancing Selectivity in Anticancer Metal Complexes. | ACS Omega | 2026 | https://conductscience.org/library/papers/42294255 | PubMed |
| 42260240 | Emerging paradigms in nanostructured targeted drug delivery systems. | Discov Nano | 2026 | https://conductscience.org/library/papers/42260240 | PubMed |
| 42245484 | Musculoskeletal disorders: does cuproptosis hold the key? | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42245484 | PubMed |
| 42226962 | Nanoparticle Drug Delivery Systems: The Future Direction for the Treatment of Tumors. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/42226962 | PubMed |
| 42220608 | Precision nanomedicine for lung metastatic osteosarcoma: challenges, therapeutic strategies, and perspectives. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42220608 | PubMed |
| 42006004 | Manganese-potentiated cGAS-STING activation with ATM/PRMT5 inhibition remodels the immunosuppressive microenvironment in osteosarcoma via bone-targeted delivery. | Bioact Mater | 2026 | https://conductscience.org/library/papers/42006004 | PubMed |
| 41945876 | Hierarchical Targeting of TREM2+ Myeloid Cells via Acid-Triggered OMVs Reprogram Immunosuppression and Suppress Osteolysis in Bone-Metastatic TNBC. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41945876 | PubMed |
| 41862520 | The cytotoxic effects of glycyrrhizic acid-modified chitosan/selenium nanocomposite on osteosarcoma cancer cell line. | Sci Rep | 2026 | https://conductscience.org/library/papers/41862520 | PubMed |
| 41858577 | Novel Dual Strategy Based on EPR/AT for Optimizing Therapeutic Effect by Improving Drug Delivery System Physicochemical Properties and Regulating TME. | Int J Nanomedicine | 2026 | https://conductscience.org/library/papers/41858577 | PubMed |
| 41822119 | Recent advances in biomaterials for osteosarcoma treatment. | Regen Biomater | 2026 | https://conductscience.org/library/papers/41822119 | PubMed |
Genes43
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36944946
GET https://conductscience.org/api/papers/v1/36944946/references?page=2